Scott B. Capps, VP, Clinical Research at CRYOLIFE INC (CRY), sold 2,000 shares at $28.55 ($57K) on 2019-05-31, disclosed to the SEC on 2019-06-03.
Open-market sale of $57k CRY by VP, Clinical Research. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| CRY | SELL | 2018-09-04 | $432K | — | Filing → |
| CRY | SELL | 2017-02-24 | $364K | — | Filing → |
| CRY | SELL | 2016-02-23 | $155K | — | Filing → |